CROI 2011 Wrap-Up: Taking Research Into Practice
Joel Gallant, M.D., takes a step back from the presented research at CROI to discuss the practical implications of recent developments in the field. In this interview, he speaks about biomedical HIV prevention methods, the dry drug development pipeline (particularly for multidrug-resistant patients), the unanswered questions about inflammation, and the "when to start treatment" question. He also discusses the importance of ensuring that patients keep, and share, their medical records.

More Top Stories:

• Really Rapid Review of CROI 2011 -- and No CROI 2012 Dates
• Zinc Fingers and Gene Therapies for HIV: Mimicking the Cured Berlin Patient?
• The Slow Decline: An Update on Neurological Complications Among People With HIV
• Complete Index of Coverage

Could MicroRNA Be the Next Great Frontier in HIV/AIDS Treatment -- and Prevention?

MicroRNA (miRNA) has been found to play a critical role in some viral infections. In this video interview, Bryan Cullen, Ph.D., reviews our knowledge to date about miRNA and discusses its potential application in HIV.

More Highlights:

• Zinc Fingers and Gene Therapies for HIV: Mimicking the Cured Berlin Patient?
• The Slow Decline: An Update on Neurological Complications Among People With HIV
• Virologic Failure on HIV Treatment 40% More Likely Among African Americans Than Whites, Study Finds
• Lower Limb Fat, Higher Belly Fat Associated With Mortality in People With HIV; BMI Measurements Questioned
• Much of HIV Treatment-Related Bone Loss Occurs Early in Therapy and Is Related to Immune Recovery, Study Finds
• More

Studies in Post-Menopausal Women Reveal Potentially Higher Biological HIV Risk, as Well as Possible Tenofovir Concerns

This week, two studies shone a little light into the dark corners of HIV research in aging women. One suggests that post-menopausal women may be at a biologically higher risk for HIV; the other found potentially increased levels of tenofovir in older women.

More Highlights:

• Vaginal Tenofovir-Based Microbicide Gel Doesn't Quite Measure Up When Used Rectally, Study Shows
• Q and A: Moving PrEP From Promising Trial Result to Practical, Public Health Prevention Intervention?
• Effective HIV Prevention Programs in the U.S.
• Scientists at Retrovirus Conference Present Findings on Microbicide Gel, Truvada, Male Circumcision, ART Care by Nurses
• AIDS Gel Shown to Protect Anal Tissue From HIV
• More